Download PDF
Semin Vasc Med 2003; 03(4): 375-384
DOI: 10.1055/s-2004-815695
RISK STRATIFICATION

Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

C-Reactive Protein and Other Inflammatory Biomarkers as Predictors of Outcome Following Acute Coronary Syndromes

Antonio Abbate, Giuseppe G.L. Biondi-Zoccai, Salvatore Brugaletta, Giovanna Liuzzo, Luigi M. Biasucci
  • Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
Further Information

Publication History

Publication Date:
03 February 2004 (online)

    Permissions and Reprints

ABSTRACT

Despite diagnostic and therapeutic advances, the rate of event recurrence is still relatively high and short- and long-term prediction of risk is necessary although extremely challenging to provide optimal treatment to patients with acute coronary syndromes. Available data recommend the use of C-reactive protein (CRP) as a prognostic marker in patients with acute coronary syndromes in addition to other prognostic factors including troponin levels. Evaluation of CRP levels at time of admission should be included in the evaluation of the patient's risk profile, including clinical data, associated diseases, markers of myocardial necrosis (especially troponin levels), left ventricle performance, and age. A cutoff level of 10 mg/L for CRP may be used as a marker of higher risk for death and possibly myocardial infarction in acute coronary syndromes, and a cutoff of 3 mg/L identifies a group of patients with intermediate risk and a high rate of recurrent events.

KEYWORDS

Inflammation - acute coronary syndromes - C-reactive protein

REFERENCES

  • 1 Wallentin L, Lagerqvist B, Husted S, for the FRISC II investigators. et al . Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial.  Lancet . 2000;  356 9-16
    CrossrefPubMedSearch in Google Scholar
  • 2 Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM- PLUS) Study Investigators. Inhibition of the platelet IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.  N Engl J Med . 1998;  338 1488-1497
    CrossrefPubMedSearch in Google Scholar
  • 3 Hamm C W, Braunwald E. A classification of unstable angina revisited.  Circulation . 2000;  102 118-122
    CrossrefPubMedSearch in Google Scholar
  • 4 Patel D J, Gomma A H, Knight C J. et al . Why is recurrent myocardial ischaemia a predictor of adverse outcome in unstable angina?.  Eur Heart J . 2001;  22 1991-1996
    CrossrefPubMedSearch in Google Scholar
  • 5 Dangas G, Mehran R, Wallenstein S. et al . Correlation of angiographic morphology and clinical presentation in unstable angina.  J Am Coll Cardiol . 1997;  29 519-525
    CrossrefPubMedSearch in Google Scholar
  • 6 Vetrovec G W, Cowley M J, Overton H, Richardson D W. Intracoronary thrombus in syndromes of unstable myocardial ischemia.  Am Heart J . 1981;  102 1202-1208
    CrossrefPubMedSearch in Google Scholar
  • 7 Heeschen C, van Den Brand J M, Hamm C W, Simoons M L. Angiographic findings in patients with refractory unstable angina according to troponin T status.  Circulation . 1999;  100 1509-1514
    PubMedSearch in Google Scholar
  • 8 Hamm C W, Heeschen C, Goldmann B. et al . Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels.  N Engl J Med . 1999;  340 1623-1629
    CrossrefPubMedSearch in Google Scholar
  • 9 Lenderink T, Boersma E, Heeschen C. et al . Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA.  Eur Heart J . 2003;  24 77-85
    PubMedSearch in Google Scholar
  • 10 van der Wal C A, Becker A E, van der Loos M C, Das P K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.  Circulation . 1994;  89 36-44
    PubMedSearch in Google Scholar
  • 11 Arbustini E, Grasso M, Diegoli M. et al . Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohistochemical, and biochemical study.  Am J Cardiol . 1991;  68(suppl) 36B-50B
    CrossrefPubMedSearch in Google Scholar
  • 12 DiSciascio G, Cowley M J, Goudreau E, Vetrovec G W, Johnson D E. Histopathologic correlates of unstable ischemic syndromes in patients undergoing directional coronary atherectomy: in vivo evidence of thrombosis, ulceration, and inflammation.  Am Heart J . 1994;  128 419-426
    CrossrefPubMedSearch in Google Scholar
  • 13 Buffon A, Biasucci L M, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina.  N Engl J Med . 2002;  347 5-12
    CrossrefPubMedSearch in Google Scholar
  • 14 Biasucci L M, Liuzzo G, Colizzi C, Rizzello V. Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease.  Ital Heart J . 2001;  2 164-171
    PubMedSearch in Google Scholar
  • 15 Liuzzo G, Biasucci L M, Gallimore J R. et al . The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina.  N Engl J Med . 1994;  331 417-424
    CrossrefPubMedSearch in Google Scholar
  • 16 Ferreiros E R, Boissonnet C P, Pizarro R. et al . Independent prognostic value of C-reactive protein in unstable angina.  Circulation . 1999;  100 1958-1963
    PubMedSearch in Google Scholar
  • 17 Oltrona L, Ardissino D, Merlini P A. et al . C-reactive protein elevation and early outcome in patients with unstable angina pectoris.  Am J Cardiol . 1997;  80 1002-1006
    CrossrefPubMedSearch in Google Scholar
  • 18 Morrow D A, Rifai N, Altman E M. et al . C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis In Myocardial Infarction 11A.  J Am Coll Cardiol . 1998;  31 1460-1465
    CrossrefPubMedSearch in Google Scholar
  • 19 Benamer H, Steg P G, Benessiano J. et al . Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris.  Am J Cardiol . 1998;  82 845-850
    CrossrefPubMedSearch in Google Scholar
  • 20 Biasucci L M, Meo A, Buffon A. et al . Independent prognostic value of C-reactive protein levels for in-hospital death and myocardial infarction in unstable angina.  Circulation . 2000;  102 (suppl II) 140
    PubMedSearch in Google Scholar
  • 21 Verheggen P H M W, de Maat P M M, Manger Cats V. et al . Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function.  Eur Heart J . 1999;  20 567-574
    CrossrefPubMedSearch in Google Scholar
  • 22 Mueller C, Buettner H J, Hodgson J M. et al . Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients.  Circulation . 2002;  105 1412-1415
    CrossrefPubMedSearch in Google Scholar
  • 23 Biasucci L M, Liuzzo G, Grillo R L. et al . Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability.  Circulation . 1999;  99 855-860
    PubMedSearch in Google Scholar
  • 24 Toss H, Lindhal B, Siegbahn A, Wallentin L, for the FRISC Study Group. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease.  Circulation . 1997;  96 4204-4210
    PubMedSearch in Google Scholar
  • 25 Lindhal B, Toss H, Siegbahn A, for the FRISC Study Group. et al . Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease.  N Engl J Med . 2000;  343 1139-1147
    CrossrefPubMedSearch in Google Scholar
  • 26 Cannon C P, Weintraub W S, Demopoulos L. et al . High-sensitivity C-reactive protein (hs-CRP) to predict 6 month mortality and relative benefit of invasive vs.  conservative strategy in patients with unstable angina: primary results of the TACTICS-TIMI 18 C-reactive protein substudy. J Am Coll Cardiol . 2001;  37(suppl A) 315A
    PubMedSearch in Google Scholar
  • 27 Bazzino O, Ferreiros E R, Pizarro R, Corrado G. C-reactive protein and the stress tests for risk stratification of patients recovering from unstable angina pectoris.  Am J Cardiol . 2001;  87 1235-1239
    CrossrefPubMedSearch in Google Scholar
  • 28 Koukkenen H, Penttilä K, Kemppainen A. et al . C-reactive protein, fibrinogen, interleukin-6 and tumor necrosis factor-α in the prognostic classification of unstable angina pectoris.  Ann Med . 2001;  33 37-47
    PubMedSearch in Google Scholar
  • 29 Rebuzzi A, Quaranta G, Liuzzo G. et al . Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris.  Am J Cardiol . 1998;  82 715-719
    CrossrefPubMedSearch in Google Scholar
  • 30 Haverkate F, Thompson S G, Pyke S D, Gallimore J R, Pepys M B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.  Lancet . 1997;  349 462-466
    CrossrefPubMedSearch in Google Scholar
  • 31 Heeschen C, Hamm C W, Bruemmer J, for the CAPTURE Investigators. et al . Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis.  J Am Coll Cardiol . 2000;  35 1535-1542
    CrossrefPubMedSearch in Google Scholar
  • 32 Buffon A, Liuzzo G, Biasucci L M. et al . Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty.  J Am Coll Cardiol . 1999;  34 1512-1521
    PubMedSearch in Google Scholar
  • 33 Chew D P, Bhatt D L, Robbins M A. et al . Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention.  Circulation . 2001;  104 992-997
    PubMedSearch in Google Scholar
  • 34 Versaci F, Gaspardone A, Tomai F. et al . Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation.  Am J Cardiol . 2000;  85 92-95
    CrossrefPubMedSearch in Google Scholar
  • 35 Walter D H, Fichtlscherer S, Sellwig M. et al . Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation.  J Am Coll Cardiol . 2001;  37 839-846
    CrossrefPubMedSearch in Google Scholar
  • 36 de Winter J R, Heyde G S, Koch K T. et al . The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty.  Eur Heart J . 2002;  23 960-966
    CrossrefPubMedSearch in Google Scholar
  • 37 Ellis S G, Chew D, Chan A, Whitlow P L, Schneider J P, Topol E J. Death following creatine kinase-MB elevation after coronary intervention.  Circulation . 2002;  106 1205-1210
    CrossrefPubMedSearch in Google Scholar
  • 38 Versaci F, Gaspardone A, Tomai F. et al . Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).  J Am Coll Cardiol . 2002;  40 1935-1942
    CrossrefPubMedSearch in Google Scholar
  • 39 de Lemos A J, Morrow D A, Bentley J H. et al . The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.  N Engl J Med . 2001;  345 1014-1021
    CrossrefPubMedSearch in Google Scholar
  • 40 de Lemos A J, Morrow D A, Bentley J H. et al . The prognostic value of B-type natriuretic peptide and acute coronary syndromes.  N Engl J Med . 2001;  345(14) 1014-1021
    CrossrefPubMedSearch in Google Scholar
  • 41 Sabatine M S, Morrow D A, de Lemos A J. et al . Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.  Circulation . 2002;  105 1760-1763
    CrossrefPubMedSearch in Google Scholar
  • 42 Zebrack J S, Muhlestein J B, Horne B D, Anderson J L, for the Intermountain Heart Collaboration Study Group. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.  J Am Coll Cardiol . 2002;  39 632-637
    CrossrefPubMedSearch in Google Scholar
  • 43 Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation.  N Engl J Med . 1999;  340 448-454
    CrossrefPubMedSearch in Google Scholar
  • 44 Biasucci L M, Vitelli A, Liuzzo G. et al . Elevated levels of interleukin-6 in unstable angina.  Circulation . 1996;  94 874-877
    PubMedSearch in Google Scholar
  • 45 Biasucci L M, Liuzzo G, Fantuzzi G. et al . Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events.  Circulation . 1999;  99 2079-2084
    PubMedSearch in Google Scholar
  • 46 Koukkunen H, Penttilä K, Kemppainen A. et al . C-reactive protein, fibrinogen, interleukin-6 and tumor necrosis factor-α in the prognostic classification of unstable angina pectoris.  Ann Med . 2001;  33 37-47
    PubMedSearch in Google Scholar
  • 47 Liuzzo G, Kopecky S L, Frye R L. et al . Perturbation of the T-cell repertoire in patients with unstable angina.  Circulation . 1999;  100 2135-2139
    PubMedSearch in Google Scholar
  • 48 Thompson S G, Kienast J, Pyke S D. et al . Hemostatic factors and of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.  N Engl J Med . 1995;  332 635-641
    CrossrefPubMedSearch in Google Scholar
  • 49 Wallen N H, Held C, Rehnqvist N, Hjemdhal P. Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction.  Eur Heart J . 1999;  20 1039-1043
    CrossrefPubMedSearch in Google Scholar
  • 50 Mulvihill N T, Foley J B, Murphy R T, Curtin R, Crean P A, Walsh M. Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules.  Heart . 2001;  85 623-627
    CrossrefPubMedSearch in Google Scholar
  • 51 Ridker P M, Rifai N, Pfeffer M. et al . Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.  Circulation . 2000;  101 2149-2153
    CrossrefPubMedSearch in Google Scholar
  • 52 Abbate A, Vecile E, Fiotti N. et al . Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction.  Eur J Heart Fail . 2003;  5 23-25
    PubMedSearch in Google Scholar
  • 53 Patti G, Di Sciascio G, D'Ambrosio A, Dicuonzo G, Abbate A, Dobrina A. Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention.  Am J Cardiol . 2002;  89 372-376
    CrossrefPubMedSearch in Google Scholar
  • 54 Blankenberg S, Tiret L, Bickel C. et al . Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina.  Circulation . 2002;  105 143-149
    CrossrefPubMedSearch in Google Scholar
  • 55 Biasucci L M, Santamaria M, Angiolillo D J. et al . Interleukin-18 levels suggest different inflammatory pathways in unstable angina-18.  J Am Coll Cardiol . 2003;  41(6 Suppl B) 363
    PubMedSearch in Google Scholar
  • 56 Ridker P M, Rifai N, Clearfield M. >for the Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. et al. Measurement of C-reactive protein for targeting of statin therapy in the primary prevention of acute coronary events.  N Engl J Med . 2001;  344 1959-1965
    CrossrefPubMedSearch in Google Scholar
  • 57 Kennon S, Price C P, Mills P G. et al . The effect of aspirin on C-reactive protein as a marker of risk in unstable angina.  J Am Coll Cardiol . 2001;  37 1266-1270
    CrossrefPubMedSearch in Google Scholar
  • 58 Chew D P, Bhatt D L, Robbins M A. et al . Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.  Am J Cardiol . 2001;  88 672-674
    CrossrefPubMedSearch in Google Scholar
  • 59 Buffon A, Liuzzo G, Angiolillo D J. et al . Abciximab decreases cytokine production by circulating monocytes in patients with unstable angina and elevated inflammatory markers.  J Am Coll Cardiol . 2001;  37 (suppl A) 818A
    CrossrefPubMedSearch in Google Scholar
  • 60 Lincoff A M, Kereiakes D J, Mascelli M A. et al . Abciximab depresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization.  Circulation . 2001;  104 163-167
    PubMedSearch in Google Scholar
  • 61 Jialal I, Stein D, Balis D. et al . Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels.  Circulation . 2001;  103 1933-1935
    PubMedSearch in Google Scholar
  • 62 Ottenvanger J P, Armstrong P, Barnathan E S. et al . Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina.  Circulation . 2003;  107 437-442
    CrossrefPubMedSearch in Google Scholar
  • 63 Albert M A, Glynn R J, Ridker P M. Alcohol consumption and plasma concentration of C-reactive protein.  Circulation . 2003;  107 443-447
    CrossrefPubMedSearch in Google Scholar
  • 64 Bhatt D L, Topol E J. Need to test the arterial inflammation hypothesis.  Circulation . 2002;  106 136-140
    CrossrefPubMedSearch in Google Scholar
  • 65 Pearson T A, Mensah G A, Alexander R W. et al . Markers of inflammation and cardiovascular disease. Application to clinical and public health practice.  Circulation . 2003;  107 499-511
    CrossrefPubMedSearch in Google Scholar
  • 66 Bertrand M E, Simoons M L, Fox K AA. et al . Management of acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology.  Eur Heart J . 2000;  21 1406-1432
    CrossrefPubMedSearch in Google Scholar
  • 67 Horne B D, Muhlestein J B, Carlquist J F. et al . Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease.  J Am Coll Cardiol . 2000;  36 1774-1780
    PubMedSearch in Google Scholar
  • 68 Zebrack J S, Anderson J L, Maycock C A. et al . Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.  Am J Cardiol . 2002;  89 145-149
    CrossrefPubMedSearch in Google Scholar